MAPT and breast carcinoma: HRT, while proposed by some to be protective against AD [90], increases risk of breast cancer, particularly ER-positive breast cancer [99], and the associations of oestrogen with reduced tau levels may offer further insight into this enhanced risk, but this is currently unknown.